Clinical Trial Update: RAltegravir Switch STudy: Effects on Endothelial Recovery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating switching to raltegravir and its effect on endothelial recovery in HIV-infected individuals. The study is sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: UMC Utrecht | Conditions: HIV Infection, Endothelial Dysfunction | Phase 4 | Status: UNKNOWN